Neurimmune AG
- Biotech or pharma, therapeutic R&D
Neurimmune is a biopharmaceutical company developing novel drug candidates for CNS and related protein aggregation diseases including Alzheimer’s disease, ALS, frontotemporal dementia and ATTR cardiomyopathy.